Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive aerosolized amikacin (BAY 41-6551) in mechanically ventilated patients with gram-negative pneumonia
2008-000906-35Phase 3Completed
- Sponsor
- Bayer
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pneumonia comparing Aerosolized amikacin arm with Placebo arm (2 arms). Primary endpoint: Clinical cure at Test-of-Cure (TOC) visit. Started Sep 2008; status: completed.
02
Drugs
amikacin
03
Conditions
pneumonia
Beyond the preview
Go deeper on 2008-000906-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000906-35.